Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026) is a clinical research site located in Omaha, Nebraska, United States 68130.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026) has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Prostate Cancer, Prostatic Neoplasms, Metastatic Castration-resistant Prostate Cancer (mCRPC).
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026) has 2 clinical trials on record, with 2 currently active. Their work covers Prostate Cancer, Prostatic Neoplasms, Metastatic Castration-resistant Prostate Cancer (mCRPC).
Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.